{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-044381","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2026-09-25T21:15:39+00:00","discovered_at":"2026-09-25T21:26:05.416147+00:00","generated_at":"2026-10-12T13:27:19.746496+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Calidi Biotherapeutics hit with NYSE American notice; equity $3.1M vs $4.0M required","bullets":["NYSE American notice dated Sept 21, 2026: stockholders' equity of $3.1M at June 30, 2026 is below the $4.0M minimum required by Company Guide Section 1003(a)(ii).","Standard was triggered because Calidi reported net losses in three of its four most recent fiscal years ended December 31, 2025.","Company must submit a compliance plan by Oct 21, 2026 and regain compliance by March 21, 2028; it is not eligible for any Section 1003(a) exemption, including the $50M market-cap exemption.","CLDI keeps trading on NYSE American but gets a '.BC' below-compliance designation; delisting proceedings would begin if no plan is filed or the plan is rejected.","Management says it is reviewing options and expects to submit the plan on or before the NYSE American deadline; the notice does not affect business operations or SEC reporting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-044381","json":"https://secwatch.observer/filing/0001493152-26-044381.json","markdown":"https://secwatch.observer/filing/0001493152-26-044381.md","text":"https://secwatch.observer/filing/0001493152-26-044381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226044381/0001493152-26-044381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226044381/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:27:19.746496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}